tirzepatide phase 2 obesity Presented at ECO 2025: In the SURMOUNT-5 3b trial involving adults with without type diabetes, was superior to semaglutide in reducing body weight and waist circumference. Full trial Read now: The SURPASS-EARLY trial
Pay in 4 interest-free payments of $6.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28



























